Goat Anti-Human IgA alpha chain (Alkaline Phosphatase) (ab97212)
Key features and details
- Goat Anti-Human IgA alpha chain (Alkaline Phosphatase)
- Conjugation: Alkaline Phosphatase
- Host species: Goat
- Isotype: IgG
- Suitable for: ICC, IHC-P, ELISA, WB
Related conjugates and formulations
製品の概要
-
製品名
Goat Anti-Human IgA alpha chain (Alkaline Phosphatase)
IgA 二次抗体 製品一覧 -
由来種
Goat -
ターゲット生物種
Human -
特異性
By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgA. Cross reactivity with other immunoglobulins and light chains is less than 0.1%. -
アプリケーション
適用あり: ICC, IHC-P, ELISA, WBmore details -
標識
Alkaline Phosphatase
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 6.8
Preservative: 0.09% Sodium azide
Constituents: 0.2% BSA, 0.58% Sodium chloride, 0.0095% Magnesium chloride, 0.00136% Zinc chloride, 1.19% HEPES -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
Antiserum was solid phase adsorbed to ensure class specificity. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Alkaline Phosphatase (AP). -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab97212の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ICC |
Use at an assay dependent dilution.
|
|
IHC-P |
1/100 - 1/1000.
|
|
ELISA |
1/1000 - 1/10000. (Primary ELISA)
|
|
WB |
1/1000 - 1/10000. (Chemiluminescent)
|
特記事項 |
---|
ICC
Use at an assay dependent dilution. |
IHC-P
1/100 - 1/1000. |
ELISA
1/1000 - 1/10000. (Primary ELISA) |
WB
1/1000 - 1/10000. (Chemiluminescent) |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
参考文献 (4)
ab97212 は 4 報の論文で使用されています。
- Narowski TM et al. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Cell Rep 38:110336 (2022). PubMed: 35090596
- Montero DA et al. Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli. NPJ Vaccines 5:20 (2020). PubMed: 32194997
- Premkumar L et al. The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies. medRxiv N/A:N/A (2020). PubMed: 32511572
- Premkumar L et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci Immunol 5:N/A (2020). PubMed: 32527802